Impact Factor
3.90
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.21
1,721 total citations
h5-index
47
h5 depth signal
Cited share
76.7%
332 of 433
Total citations
1,721
Citation footprint
Metric signal
4.68
External metric anchor
Self-citation
4.5%
78 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Italy
432
China
266
United States
257
Spain
236
United Kingdom
164
Citing Fields of Research
Cardiology
591
Diabetes
178
Immunology
165
Virology
116
Lipids
108
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,893
Articles tracked across the journal lifetime
Indexed publication set
433
332 cited publications
Last 12 months
136
11.3 publications/month
Open access share
52.9%
72 OA publications in the last year
Leading citing country
Italy
432 citing publications
Leading citing field
Cardiology
591 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Mar. 1970-
v1n1,Mar. 1970-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Issuing & Sponsoring Bodies
Contributor
European Society for Clinical Investigation
Broad Categories
Medicine
Cardiology
Lipids
Diabetes
Urology
Hematology
Inflammatory Bowel Diseases & Infections
MeSH Descriptors
Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/eci.70267
Open DOI
Lower, Earlier, Longer and Personalized: Rethinking Lipid‐Lowering Therapy for Cardiovascular Prevention
Atherosclerotic cardiovascular disease remains the leading cause of morbidity and mortality worldwide. Lipid‐lowering therapy represents the cornerstone of cardiovascular prevention, with low‐density lipoproteins (LDL) identified as a ca...
02
DOI 10.1111/eci.70263
Open DOI
Proprotein Convertase Subtilisin/Kexin Type 9: From Biology to Therapeutic Targeting in Cardiovascular Disease
Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a pivotal regulator of cholesterol homeostasis, primarily known for inducing the degradation of the low‐density lipoprotein receptor (LDLR). Beyond this classical pathw...
03
DOI 10.1111/eci.70261
Open DOI
Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF : A Context‐of‐Use Review
Background: Interleukin‐6 (IL‐6) is frequently measured in heart failure with reduced ejection fraction (HFrEF), but its clinical utility remains unclear. Objectives: To assess IL‐6 as a biomarker in HFrEF, with emphasis on the effect of...
04
05
06
DOI 10.1111/eci.70262
Open DOI
Delirium in Patients With Traumatic Brain Injury and Long‐Term Cognitive Decline: A Global Federated Real World Data Analysis
Background and Objective: Delirium may occur in patients with traumatic brain injury (TBI), but this may be a marker for subsequent cognitive decline post‐TBI. We aimed to compare cognitive outcomes and all‐cause mortality between TBI pa...
07
DOI 10.1111/eci.70256
Open DOI
Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous respiratory disorder driven by neutrophilic and eosinophilic inflammation, structural changes, and airflow limitation. Shared pathophysiology makes cardiovascula...
08
DOI 10.1111/eci.70230
Open DOI
Issue Information
09
DOI 10.1111/eci.70257
Open DOI
Non‐Invasive Assessment of Endothelial Dysfunction and Arterial Stiffness in Fontan Circulation
Background: The Fontan procedure constitutes the definitive surgical strategy for complex congenital heart disease, establishing a circulation in which systemic venous blood is directed to the pulmonary arteries through a staged reconstr...
10
DOI 10.1111/eci.70260
Open DOI
Prevalence of Cancer Across Cardiovascular and Cardiometabolic Conditions: A Systematic Review and Meta‐Analysis
Background: To the best of our knowledge, no previous systematic review has comprehensively quantified cancer prevalence across the broad spectrum of cardiovascular and cardiometabolic conditions included in the present study. We aimed t...
Bibliographical & Catalog Notes
Print issues ceased with v. 43, no. 12 (2013).
Also issued online.
Vol. 10, no. 1 (1980)19920818 Notice not published Printed on acid-free paper